{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T03:08:16Z","timestamp":1776827296119,"version":"3.51.2"},"reference-count":52,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pineal Research"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:p>\n                    <jats:bold>Abstract:\u2002<\/jats:bold>\n                    Melatonin is a potent free radical scavenger, antioxidant and neuroprotective drug. On the other hand, galantamine is a cholinergic drug with antioxidant and neuroprotective properties linked to inhibition of acetylcholinesterase and allosteric modulation of nicotinic receptors. This investigation evaluated a possible synergistic neuroprotective effect of subeffective concentrations of combined galantamine and melatonin. Human neuroblastoma SH\u2010SY5Y cells were subjected to a mitochondrial oxidative stress, by blockade of mitochondrial complexes I and V with rotenone and oligomycin\u2010A (R\/O); cells were treated for 24\u2003hr with R\/O. This caused 40% of the cell to die as measured by lactate dehydrogenase (LDH) release. Cell incubation with increasing concentrations of galantamine (10\u2013300\u2003n\n                    <jats:sc>m<\/jats:sc>\n                    ) or melatonin (0.3\u201310\u2003n\n                    <jats:sc>m<\/jats:sc>\n                    ) for 24\u2003hr, followed by a 24\u2010hr period with R\/O, caused a concentration\u2010dependent protection; maximum protection was achieved with 300\u2003n\n                    <jats:sc>m<\/jats:sc>\n                    galantamine (56% protection) and 10\u2003n\n                    <jats:sc>m<\/jats:sc>\n                    melatonin (50% protection). Combination of subeffective concentrations of melatonin (0.3\u2003n\n                    <jats:sc>m<\/jats:sc>\n                    ) and galantamine (30\u2003n\n                    <jats:sc>m<\/jats:sc>\n                    ) caused a synergistic and significant protection that was similar to the maximum protection afforded by effective concentrations of melatonin or galantamine alone. This protective effect was completely reversed when nicotinic and melatonin receptors were blocked respectively by mecamylamine and luzindole. The neuroprotective effect was prevented by chelerythrine, LY294002, and Sn (IV) protoporphyrin IX dichloride (SnPP), indicating the participation of the PKC\/PI3K\/Akt activation and induction of the antioxidant enzyme heme oxygenase\u20101. The synthesis of novel multitarget compounds having in a single molecule the combined neuroprotective properties of galantamine and melatonin could be a new strategy for potential therapeutic agents in neurodegenerative diseases.\n                  <\/jats:p>","DOI":"10.1111\/j.1600-079x.2010.00778.x","type":"journal-article","created":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T23:43:48Z","timestamp":1444693428000},"page":"141-148","source":"Crossref","is-referenced-by-count":71,"title":["Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH\u2010SY5Y neuroblastoma cells"],"prefix":"10.1111","volume":"49","author":[{"given":"Alejandro","family":"Romero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Egea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio G.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela G.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,6,1]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathophys.2006.05.004"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318182"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(07)82001-0"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-004-0242-8"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1989.tb09133.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-20-08126.1998"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(01)00340-2"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440518"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(90)90429-U"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2004.11.002"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/JAD-2007-11411","article-title":"Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer\u2019s neuropathology","volume":"11","author":"Coyle JT","year":"2007","journal-title":"J Alzheimers Dis"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(00)00435-4"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1385\/CBB:34:2:237"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2008.00580.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2009.00701.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/10409230903044914"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2006.00377.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(01)80124-4"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2009.00666.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03493.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.090365"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2007.10.012"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.04.029"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1006\/mcne.1993.1001"},{"key":"e_1_2_7_26_2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0026-895X(25)10029-1","article-title":"Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH\u2010SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in xenopus oocytes","volume":"45","author":"Peng X","year":"1994","journal-title":"Mol Pharmacol"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2009.04.619"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200700256"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418130-00001"},{"key":"e_1_2_7_30_2","first-page":"27","article-title":"Relative tolerability of Alzheimer\u2019s disease treatments","volume":"5","author":"Alva G","year":"2008","journal-title":"Psychiatry (Edgmont)"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1211\/002235702760345374"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(86)90368-6"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(87)90041-0"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.04.067"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.04665.x"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.11.095"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.122747"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(03)00317-4"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.10.132"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)01109-4"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-200108001-00004"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1515\/znc-2003-5-613"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00955-3"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2008.00582.x"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2009.00692.x"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008035200"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(98)00052-5"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1998.78.3.687"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb10037.x"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04213.x"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-079X.2003.00092.x"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2004.09.031"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200800414"}],"container-title":["Journal of Pineal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-079X.2010.00778.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-079X.2010.00778.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1600-079X.2010.00778.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-079X.2010.00778.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T15:28:44Z","timestamp":1772983724000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-079X.2010.00778.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1111\/j.1600-079X.2010.00778.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-079x.2010.00778.x","archive":["Portico"],"relation":{},"ISSN":["0742-3098","1600-079X"],"issn-type":[{"value":"0742-3098","type":"print"},{"value":"1600-079X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,1]]}}}